
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Chobe Capital is a venture capital firm based in China, founded in September 2016. It operates under the umbrella of 清科控股 (Zero2IPO Group), which provides a strong foundation for investment insights and services. The firm primarily focuses on early-stage and growth-stage investments, targeting the Chinese market. Chobe Capital has established itself as a key player in the investment landscape, particularly in sectors such as technology, healthcare, and consumer goods.
Since its inception, Chobe Capital has made significant strides in the investment community, with a portfolio that includes innovative companies in various sectors. The firm has a total of four investments, including notable companies like 易慕峰生物 (Yimufeng Bio) and 质子汽车 (Proton Automotive). Chobe Capital's affiliation with Zero2IPO Group enhances its capabilities, providing valuable resources and insights to its portfolio companies.
Chobe Capital is headquartered in Beijing, China, and has a focus on pre-IPO opportunities within its investment strategy. The firm is known for its commitment to supporting the growth of its portfolio companies through strategic insights and market positioning.
Chobe Capital invests across multiple sectors, including healthcare, consumer goods, and technology. The firm primarily targets early-stage and growth-stage investments, with a keen interest in pre-IPO opportunities within the Chinese market. This focus allows Chobe Capital to identify and support companies that are poised for significant growth and market impact.
The investment strategy emphasizes collaboration with innovative startups that align with its sector interests. Chobe Capital seeks to partner with founders who demonstrate strong leadership and a clear vision for their companies. The firm values companies that are addressing critical needs in healthcare and consumer sectors, particularly those leveraging technology to enhance their offerings.
Chobe Capital's check sizes typically align with the growth stage of the companies it invests in, providing the necessary capital to fuel expansion and development. The firm is committed to fostering relationships with its portfolio companies, ensuring they have access to the resources and insights needed to thrive in a competitive market.
Chobe Capital has invested in a diverse range of companies, focusing on innovative solutions within its target sectors. The current portfolio includes:
In addition to its current investments, Chobe Capital has achieved notable exits, including the successful exit of Tianjin Yiyi Hygiene Products Co., Ltd, a manufacturer of pet, adult, and baby care products. This exit highlights the firm's ability to identify and support companies that can achieve significant market success.
To pitch to Chobe Capital, founders should send an email to ranlin@zero2ipo.com.cn. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. Founders should expect a response within a few weeks, although timelines may vary based on the volume of inquiries.
Warm introductions are preferred, as they can facilitate a more favorable review of the pitch. Founders are encouraged to leverage their networks to connect with Chobe Capital or its affiliates for a better chance of engagement.
On January 27, 2025, Chobe Capital made a recent investment in Nali New Materials, although the amount raised has not been disclosed. This investment reflects the firm's ongoing activity in the market, despite being listed as permanently closed on some platforms.
Chobe Capital has a total of four investments, including notable companies like 易慕峰生物 (Yimufeng Bio) and 质子汽车 (Proton Automotive). The firm continues to focus on pre-IPO opportunities within the Chinese market, indicating a commitment to supporting innovative companies.
What are Chobe Capital's investment criteria?
Chobe Capital focuses on early-stage and growth-stage investments in sectors such as healthcare, consumer goods, and technology. The firm seeks companies that demonstrate strong growth potential and innovative solutions, particularly those preparing for pre-IPO opportunities.
How can founders apply or pitch to Chobe Capital?
Founders can pitch to Chobe Capital by sending an email to ranlin@zero2ipo.com.cn. It is advisable to include a detailed business plan and financial projections in the pitch deck to provide a comprehensive overview of the startup.
What makes Chobe Capital different from other venture capital firms?
Chobe Capital's affiliation with 清科控股 (Zero2IPO Group) provides it with unique insights and resources that enhance its investment capabilities. This connection allows the firm to offer valuable support to its portfolio companies, helping them navigate the complexities of the Chinese market.
What is the geographic scope of Chobe Capital's investments?
The firm primarily invests in the Chinese market, focusing on companies that are based in or targeting the region. This geographic focus allows Chobe Capital to leverage its local expertise and network effectively.
What is the typical check size for investments made by Chobe Capital?
While specific check sizes are not disclosed, Chobe Capital typically invests in early-stage and growth-stage companies, providing the necessary capital to support their development and expansion efforts.
What kind of post-investment involvement does Chobe Capital have with its portfolio companies?
Chobe Capital actively engages with its portfolio companies, offering strategic insights and resources to enhance their growth potential. The firm aims to build strong relationships with founders and provide ongoing support throughout the investment lifecycle.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.